Sector Update: Health Care Stocks Softer Late Afternoon

MT Newswires Live

08/29

Health care stocks were lower late Thursday afternoon, with the NYSE Health Care Index shedding 0.6% and the Health Care Select Sector SPDR Fund (XLV) down 0.5%

The iShares Biotechnology ETF (IBB) decreased 0.4%.

In corporate news, Outlook Therapeutics (OTLK) shares tumbled 54% after it said Thursday the US Food and Drug Administration issued a complete response letter to its resubmitted biologics license application for ONS-5010 to treat wet age-related macular degeneration. The regulator cited a lack of substantial evidence of effectiveness, noting the therapy failed to meet the primary endpoint for effectiveness in a study, Outlook Therapeutics said.

Cooper (COO) shares lost more than 12% after several investment firms cut their price targets on the stock following the company's fiscal Q3 results on Wednesday.

Telix Pharmaceutical (TLX) shares fell past 16% after the company said the US Food and Drug Administration has requested additional data on its biologics license application for Zircaix, an investigational PET agent for diagnosing clear cell renal cell carcinoma.

Walgreens Boots Alliance (WBA) said Thursday that it has been acquired by Sycamore Partners, and will now operate as a private entity.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2563065618"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2563065618\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2563065618?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-29 03:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2563065618","market":"sg","top_or_hot":-1,"title":"Sector Update: Health Care Stocks Softer Late Afternoon","media":"MT Newswires Live","content":"<html><body><p> Health care stocks were lower late Thursday afternoon, with the NYSE Health Care Index shedding 0.6% and the Health Care Select Sector SPDR Fund (XLV) down 0.5%</p><p>The <a href=\"https://laohu8.com/S/EEMA\">iShares</a> Biotechnology ETF (IBB) decreased 0.4%.</p><p>In corporate news, Outlook <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (OTLK) shares tumbled 54% after it said Thursday the US Food and Drug Administration issued a complete response letter to its resubmitted biologics license application for ONS-5010 to treat wet age-related macular degeneration. The regulator cited a lack of substantial evidence of effectiveness, noting the therapy failed to meet the primary endpoint for effectiveness in a study, Outlook Therapeutics said.</p><p>Cooper (COO) shares lost more than 12% after several investment firms cut their price targets on the stock following the company's fiscal Q3 results on Wednesday.</p><p>Telix Pharmaceutical (TLX) shares fell past 16% after the company said the US Food and Drug Administration has requested additional data on its biologics license application for Zircaix, an investigational PET agent for diagnosing clear cell renal cell carcinoma.</p><p>Walgreens Boots Alliance (WBA) said Thursday that it has been acquired by Sycamore Partners, and will now operate as a private entity.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sector Update: Health Care Stocks Softer Late Afternoon</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSector Update: Health Care Stocks Softer Late Afternoon\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2025-08-29 03:40</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> Health care stocks were lower late Thursday afternoon, with the NYSE Health Care Index shedding 0.6% and the Health Care Select Sector SPDR Fund (XLV) down 0.5%</p><p>The <a href=\"https://laohu8.com/S/EEMA\">iShares</a> Biotechnology ETF (IBB) decreased 0.4%.</p><p>In corporate news, Outlook <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (OTLK) shares tumbled 54% after it said Thursday the US Food and Drug Administration issued a complete response letter to its resubmitted biologics license application for ONS-5010 to treat wet age-related macular degeneration. The regulator cited a lack of substantial evidence of effectiveness, noting the therapy failed to meet the primary endpoint for effectiveness in a study, Outlook Therapeutics said.</p><p>Cooper (COO) shares lost more than 12% after several investment firms cut their price targets on the stock following the company's fiscal Q3 results on Wednesday.</p><p>Telix Pharmaceutical (TLX) shares fell past 16% after the company said the US Food and Drug Administration has requested additional data on its biologics license application for Zircaix, an investigational PET agent for diagnosing clear cell renal cell carcinoma.</p><p>Walgreens Boots Alliance (WBA) said Thursday that it has been acquired by Sycamore Partners, and will now operate as a private entity.</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2272731600.USD","symbol_name":"Allianz Global Intelligent Cities AM Dis USD","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2563065618","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2563065618","pubTimestamp":1756410022,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Health care stocks were lower late Thursday afternoon, with the NYSE Health Care Index shedding 0.6% and the Health Care Select Sector SPDR Fund (XLV) down 0.5%The iShares Biotechnology ETF (IBB) decr","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU2272731600.USD":"Allianz Global Intelligent Cities AM Dis USD","COO.AU":"Corum Group Ltd","XLV":"健康照护类股ETF-SPDR","BK4198":"医疗保健用品","BK4585":"ETF&股票定投概念","GB00BDT5M118.USD":"天利环球扩展Alpha基金A Acc","BK4139":"生物科技","WBA.AU":"Webster Ltd","LU2211815571.USD":"ALLIANZ POSITIVE CHANGE \"AT\" (USD) ACC","WBA":"沃尔格林联合博姿","LU1992135399.USD":"Allianz Global Intelligent Cities AT Acc USD","LU0321505868.SGD":"Schroder ISF Global Dividend Maximiser A Dis SGD","LU0321505439.SGD":"Schroder ISF Global Dividend Maximiser A Acc SGD","COO":"库珀医疗","BK7016":"应用软件","TLX":"Telix Pharmaceuticals Ltd. (Uplisting)","BK4588":"碎股","LU1992135472.HKD":"ALLIANZ GLOBAL INTELLIGENT CITIES \"AT\" (HKD) ACC","IBB":"生物科技指数ETF-iShares Nasdaq","TLX.AU":"TELIX PHARMACEUTICALS LTD","BK4128":"药品零售","BK7067":"生物科技","LU2272731782.SGD":"Allianz Global Intelligent Cities AM Dis H2-SGD","OTLK":"Outlook Therapeutics, Inc.","BK4581":"高盛持仓"},"translate_title":"行业更新：医疗保健股午后走软","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"WBA.AU":1,"COO.AU":1,"OTLK":0.9,"WBA":0.9,"COO":0.9,"TLX":0.9,"IBB":1,"TLX.AU":1,"XLV":1},"content_text":"Health care stocks were lower late Thursday afternoon, with the NYSE Health Care Index shedding 0.6% and the Health Care Select Sector SPDR Fund (XLV) down 0.5%The iShares Biotechnology ETF (IBB) decreased 0.4%.In corporate news, Outlook Therapeutics (OTLK) shares tumbled 54% after it said Thursday the US Food and Drug Administration issued a complete response letter to its resubmitted biologics license application for ONS-5010 to treat wet age-related macular degeneration. The regulator cited a lack of substantial evidence of effectiveness, noting the therapy failed to meet the primary endpoint for effectiveness in a study, Outlook Therapeutics said.Cooper (COO) shares lost more than 12% after several investment firms cut their price targets on the stock following the company's fiscal Q3 results on Wednesday.Telix Pharmaceutical (TLX) shares fell past 16% after the company said the US Food and Drug Administration has requested additional data on its biologics license application for Zircaix, an investigational PET agent for diagnosing clear cell renal cell carcinoma.Walgreens Boots Alliance (WBA) said Thursday that it has been acquired by Sycamore Partners, and will now operate as a private entity.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}